BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in BioLineRx Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +1 vs. Q2 2022
- Shares held
- 11.2M
- +10.1M (+961.4%) vs. Q2 2022
- Total value
- $10.3M
- +$8.98M (+667.4%) vs. Q2 2022
- New holders
- 8
- 5 more added
- Sold out
- 7
- 6 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $206.7K |
| Q1 2026 | 13 | $45.2K |
| Q4 2025 | 14 | $135.6K |
| Q3 2025 | 14 | $104.3K |
| Q2 2025 | 17 | $302.1K |
| Q1 2025 | 12 | $28.0K |
| Q4 2024 | 32 | $435.9K |
| Q3 2024 | 32 | $1.34M |
| Q2 2024 | 31 | $2.42M |
| Q1 2024 | 28 | $1.47M |
| Q4 2023 | 29 | $1.75M |
| Q3 2023 | 29 | $2.46M |
| Q2 2023 | 26 | $1.97M |
| Q1 2023 | 20 | $2.91M |
| Q4 2022 | 18 | $3.37M |
| Q3 2022 | 28 | $10.3M |
| Q2 2022 | 28 | $1.36M |
| Q1 2022 | 26 | $1.99M |
| Q4 2021 | 30 | $5.09M |
| Q3 2021 | 30 | $6.69M |
| Q2 2021 | 30 | $4.01M |
| Q1 2021 | 29 | $13.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Altium Capital Management LP | 4,149,262 | $3.84M | 1.44% | +4,149,262 | New |
| Sabby Management, LLC | 3,034,107 | $2.81M | 6.08% | +3,034,107 | New |
| Armistice Capital, LLC | 2,797,048 | $2.59M | 0.07% | +2,797,048 | New |
| Parkman Healthcare Partners LLC | 288,852 | $267.0K | 0.08% | +3,398+1.2% | Added |
| Morgan Stanley | 262,559 | $243.0K | 0.00% | +10,375+4.1% | Added |
| Atria Wealth Solutions, Inc. | 104,032 | $96.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 68,222 | $63.0K | 0.00% | +22,478+49.1% | Added |
| Apollon Wealth Management, LLC | 48,790 | $45.0K | 0.00% | +48,790 | New |
| PVG Asset Management Corp | 47,860 | $44.3K | 0.17% | +47,860 | New |
| LPL Financial LLC | 46,576 | $43.0K | 0.00% | −4,000−7.9% | Reduced |
| Virtu Financial LLC | 46,168 | $43.0K | 0.00% | +30,551+195.6% | Added |
| Geode Capital Management, LLC | 32,026 | $29.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 29,839 | $28.0K | 0.00% | −21,511−41.9% | Reduced |
| Two Sigma Securities, LLC | 30,394 | $28.0K | 0.00% | +30,394 | New |
| ACT Capital Management, LLC | 27,500 | $25.0K | 0.03% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 23,500 | $21.0K | 0.00% | −17,950−43.3% | Reduced |
| Cutter & CO Brokerage, Inc. | 18,667 | $17.0K | 0.01% | 00.0% | Unchanged |
| Opaleye Management Inc. | 16,667 | $16.0K | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 17,092 | $16.0K | 0.00% | +2,533+17.4% | Added |
| Creative Planning | 14,582 | $13.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 14,200 | $13.0K | 0.00% | −200−1.4% | Reduced |
| Millennium Management LLC | 13,403 | $12.0K | 0.00% | +13,403 | New |
| UBS Group AG | 12,793 | $12.0K | 0.00% | +12,793 | New |
| Advisor Group Holdings, Inc. | 10,657 | $10.0K | 0.00% | −2,790−20.7% | Reduced |
| Group One Trading, L.P. | 9,623 | $9.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,053 | $2.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 206 | $0 | 0.00% | −1,529−88.1% | Reduced |
| Wells Fargo & Company | 35 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −22,774−100.0% | Sold out |
| Thomasville National Bank | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,390−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −1,333−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,147−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Urban Wealth Management, LLC | – | – | – | – | Not filed |